Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
HTG MOLECULAR DIAGNOSTICS, INC (HTGM)
|
|
Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
In millions, except per share items | Mar-31-23 | Mar-05-23 | Jun-30-22 | Mar-31-22 | Mar-05-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 |
| 10-Q | 8-K | 10-Q | 10-Q | 8-K | 10-K | 10-Q | 10-Q |
Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
Cost of goods sold | 111.3% | 0.0% | 68.0% | 72.2% | 0.0% | 47.1% | 39.0% | 46.8% |
Gross profit | -11.3% | 100.0% | 32.0% | 27.8% | 100.0% | 52.9% | 61.0% | 53.2% |
Selling, general and administrative | 474.1% | -2803.6% | 412.6% | 555.8% | 1415.6% | | 167.9% | 250.0% |
Research and development | | -1377.1% | | | 583.0% | 66.1% | 60.9% | |
General and administrative | | | | | | 158.2% | | |
EBITDA | -484.9% | 4280.7% | -397.0% | -553.4% | -1898.6% | -166.0% | -160.2% | -45.2% |
Depreciation | 8.3% | | 11.2% | 15.7% | | 5.3% | 7.7% | 8.6% |
EBIT | -493.2% | 4280.7% | -408.3% | -569.1% | -1898.6% | -171.3% | -167.8% | -53.8% |
Pre-tax income | -489.3% | 0.0% | -394.4% | -548.5% | 0.0% | -180.4% | -178.1% | -125.3% |
Income taxes | 0.2% | 1.9% | 0.3% | 0.0% | -0.1% | 0.1% | 0.1% | 0.8% |
Net income | -489.6% | 0.0% | -394.8% | -548.6% | 0.0% | -180.4% | -178.2% | -126.1% |
|